You have access
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint Inhibitors
KIYOHIRO ANDO, KAZUYUKI HAMADA, MAKOTO WATANABE, RYOTARO OHKUMA, MIDORI SHIDA, RIE ONOUE, YUTARO KUBOTA, HIROTO MATSUI, TOMOYUKI ISHIGURO, YUYA HIRASAWA, HIROTSUGU ARIIZUMI, JUNJI TSURUTANI, KIYOSHI YOSHIMURA, TAKUYA TSUNODA, SHINICHI KOBAYASHI and SATOSHI WADA
Anticancer Research September 2019, 39 (9) 5195-5201; DOI: https://doi.org/10.21873/anticanres.13716